Keyphrases
Antiviral Protein
14%
Blood Samples
14%
Clinical Trials
14%
COVID-19
100%
COVID-19 Patients
57%
Hepatitis Virus
14%
Immune Cells
14%
Immune Defense
14%
Immune Plasma
14%
Immune System
28%
Infected Patients
14%
Interferon lambda (IFN-λ)
100%
Interferon-α (IFN-α)
42%
Lung
14%
Multiple Virus
14%
Natural Defenses
14%
Viral Clearance
14%
Virus
42%
Virus Infection
14%
Medicine and Dentistry
Antiserum
14%
Antiviral Protein
14%
Clinical Study
14%
Clinical Trial
14%
COVID-19
100%
Hepatitis Virus
14%
Immune System
28%
Immunity
14%
Immunocompetent Cell
14%
Interferon
42%
Interleukin 29
100%
Lung
14%
Severe Acute Respiratory Syndrome Coronavirus 2
42%
Side Effect
14%
Viral Clearance
14%
Virus
57%
Virus Infection
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
14%
Clinical Study
14%
Clinical Trial
14%
Interferon
42%
Interleukin 29
100%
SARS Coronavirus
42%
Side Effect
14%
Viral Clearance
14%
Virus Hepatitis
14%
Virus Infection
14%